Trial intelligence / Profile preview

Postoperative enoxaparin after hepatobiliary-pancreatic cancer surgery

jRCT1051190020Phase 2Completed

Start
Apr 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of enoxaparin in hepatopancreatobiliary malignancy, venous thromboembolism (VTE). Started Apr 2015; status: completed.

02

Drugs

enoxaparin
03

Conditions

hepatopancreatobiliary malignancyvenous thromboembolism (VTE)

Beyond the preview

Go deeper on jRCT1051190020.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1051190020.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call